Eyes With Type 1 ROP Show Benefit Of Early Treatment At 6 Years | OphthalmologyWeb: The Ultimate Online Resource for Ophthalmologists

Friday, July 29, 2011

Email

Comments

Ocular Surgery News

Early treatment of type 1 retinopathy of prematurity may improve grating visual acuity outcomes, a study found.

Retina Products and Equipment »

All of the following drugs are FDA approved for the treatment of predominantly classic subfoveal CNV in patients with neovascular AMD except for which one?
1. Pegaptanib sodium (Macugen)
2. Verteporfin (Visudyne PDT)
3. Ranibizumab (Lucentis)
4. Bevacizumab (Avastin)
5. All of the above
Check The Answer

CareCloud Central
CareCloud Central is a medical practice ... view product
Selecta Trio™ YAG Laser, SLT and Photocoagulation
The Lumenis Selecta® Trio™ ... view product

View all Featured Products »

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

Learn more about writing for us